533

REGIONAL MICROBIOTA MISMATCHES FROM FECAL MICROBIOTA TRANSPLANTS DRIVE PERSISTENT, OFF-TARGET CONSEQUENCES TO THE HOST

Date
May 19, 2024

Fecal microbiota transplant (FMT) is a promising, novel intervention to promote restitution and repair of colonic dysbiosis. However, the appropriateness of FMT to fully reconstitute all parts of the gut must be questioned given that most preparations are comprised of colonic anaerobic microbes not indigenous or fit to inhabit the small intestine. Mismatches between regional host gut ecosystems and their microbiota could have adverse consequences to the host. We hypothesized that colonic microbiota will not properly restore the microbiome of the small intestine (and vice versa) and that this will have both short- and long-term regional and systemic consequences on immunity and metabolism. We treated male and female SPF (specific pathogen free) mice with antibiotics and performed jejunal, cecal, or fecal microbiota transplant (JMT, CMT, FMT, respectively) and compared them to their saline or no antibiotic controls (n>7 per group, 1 and 3 months post transplant) (Fig.1). JMT and FMT resulted in distinct, altered regional gut microbiota membership and function (P<0.001, PERMANOVA and Mann-Whitney). Importantly, these microbial changes corresponded to distinct shifts in circulating and regional gut metabolite pools, as well as intestinal and hepatic transcriptional programs that persisted up to three months. Whereas JMT primarily impacted host metabolic pathways, FMT largely affected immune pathways – highlighting the extraordinary and dichotomous impact of these two donor microbiota populations (Fig.2). We found that small and large bowel microbes influence intestinal mucosal identity, whereby regional microbes drove marker gene expression and function of the jejununal and colonic mucosa. Lastly, energy balance, respiratory exchange ratios, locomotor activity, glucose tolerance, and insulin resistance were shifted in a transplant-dependent manner revealing the global, metabolic impacts of regional gut microbial mismatches. Together, these data draw attention to the impact of regional mismatches between microbiota and ecosystem on global host physiology, immunity, and metabolism. This study addresses potential limitations and unintended consequences of current FMT practices and leads to a rethinking of strategies for the development of future live biotherapeutic products (LBPs) for clinical practice.
<b>Fig1.</b> <b>Graphical Abstract. </b>Small and large bowel microbial transplants (JMT and FMT, respectively) were performed in post antibiotic C57Bl6 male and female mice and compared to their no antibiotic and saline controls after 1 and 3-months (n<u>></u>7 per group). Mice demonstrated significant differences in energy balance and intestinal and hepatic metabolism, microbial engraftment, and metabolite pools.

Fig1. Graphical Abstract. Small and large bowel microbial transplants (JMT and FMT, respectively) were performed in post antibiotic C57Bl6 male and female mice and compared to their no antibiotic and saline controls after 1 and 3-months (n>7 per group). Mice demonstrated significant differences in energy balance and intestinal and hepatic metabolism, microbial engraftment, and metabolite pools.

<b>Fig2. Hepatic metabolic pathways are enriched in JMT-treated mice whereas immune pathways are enriched in FMT-treated mice.</b> Male C57Bl6 mice were treated for 14 days with antibiotics, followed by a 2-day recovery period, and then given JMT, CMT, FMT or sterile saline via oral gavage. One-month post-MT, hepatic samples were subjected to RNAseq. Differences in gene transcripts are depicted in the PCA plot in <b>A</b> and KEGG pathway analysis shown in <b>B</b> (n=7 per group).

Fig2. Hepatic metabolic pathways are enriched in JMT-treated mice whereas immune pathways are enriched in FMT-treated mice. Male C57Bl6 mice were treated for 14 days with antibiotics, followed by a 2-day recovery period, and then given JMT, CMT, FMT or sterile saline via oral gavage. One-month post-MT, hepatic samples were subjected to RNAseq. Differences in gene transcripts are depicted in the PCA plot in A and KEGG pathway analysis shown in B (n=7 per group).


Tracks

Related Products

Thumbnail for THE IMPACT OF FOOD ADDITIVE INTAKE AND ALTERED GUT MICROBIOME ON PERINATAL HEALTH: DATA FROM 3 REGIONS IN CHINA FROM THE MOMMY COHORT
THE IMPACT OF FOOD ADDITIVE INTAKE AND ALTERED GUT MICROBIOME ON PERINATAL HEALTH: DATA FROM 3 REGIONS IN CHINA FROM THE MOMMY COHORT
KEYWORDS: food additives, maternal gut microbiome, gestational diabetes mellitus, large for gestational age
Thumbnail for FAECAL MICROBIOTA TRANSPLANTATION FOR POST-ACUTE COVID-19 SYNDROME: AN OPEN-LABEL PILOT TRIAL (FMT-PACS STUDY)
FAECAL MICROBIOTA TRANSPLANTATION FOR POST-ACUTE COVID-19 SYNDROME: AN OPEN-LABEL PILOT TRIAL (FMT-PACS STUDY)
BACKGROUND: Post-acute COVID-19 syndrome (PACS) affects sleep and neuropsychiatric functions but treatment is limited. We aimed to assess the effects of faecal microbiota transplantation (FMT) in alleviating post-COVID insomnia and anxiety…
Thumbnail for FAECAL MICROBIOME AS TARGETED NON-INVASIVE BIOMARKERS FOR INFLAMMATORY BOWEL DISEASE: A CROSS-POPULATION METAGENOMIC ANALYSIS IN SIX COHORTS
FAECAL MICROBIOME AS TARGETED NON-INVASIVE BIOMARKERS FOR INFLAMMATORY BOWEL DISEASE: A CROSS-POPULATION METAGENOMIC ANALYSIS IN SIX COHORTS
BACKGROUND Emerging data support the importance of gut microbiome alterations in the pathogenesis of inflammatory bowel disease (IBD) but their role as non-invasive biomarkers for IBD has not been unexplored…
Thumbnail for THE IMPACT OF COVID-19 ON EARLY LIFE GUT MICROBIOME: IMPLICATIONS FROM TWO INDEPENDENT MOTHER-BABY DYAD COHORTS IN THE GREATER BAY AREA OF CHINA
THE IMPACT OF COVID-19 ON EARLY LIFE GUT MICROBIOME: IMPLICATIONS FROM TWO INDEPENDENT MOTHER-BABY DYAD COHORTS IN THE GREATER BAY AREA OF CHINA
BACKGROUND: Through shotgun metagenomic sequencing, we identified the depletion of probiotic species_ Lactobacillus acidophilus_ in stools of mice with non-alcoholic fatty liver disease-associated hepatocellular carcinoma (NAFLD-HCC)…